Trial intelligence / Profile preview

The ASPIRE Trial: Corticosteroid Injections for Achilles Tendinopathy

NCT07650396Phase 3Recruiting

Sponsor
Erasmus MC
Start
Jun 2026
Primary completion
Dec 2027
Countries
1
01

Overview

A Phase 3 trial of methylprednisolone in Achilles tendinopathy, sponsored by Erasmus MC. Started Jun 2026; status: recruiting.

02

Drugs

methylprednisolone
03

Conditions

Achilles tendinopathy

Beyond the preview

Go deeper on NCT07650396.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07650396.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call